BE846837A - Composes et compositions a activite antiallergique et anti-anaphylactique, - Google Patents

Composes et compositions a activite antiallergique et anti-anaphylactique,

Info

Publication number
BE846837A
BE846837A BE171148A BE171148A BE846837A BE 846837 A BE846837 A BE 846837A BE 171148 A BE171148 A BE 171148A BE 171148 A BE171148 A BE 171148A BE 846837 A BE846837 A BE 846837A
Authority
BE
Belgium
Prior art keywords
antiallergic
compositions
compounds
antianaphylactic
activity
Prior art date
Application number
BE171148A
Other languages
English (en)
French (fr)
Inventor
L A Svenseon
L M Sorenby
K I L Wetterlin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE846837A publication Critical patent/BE846837A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/04Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reaction of ammonia or amines with olefin oxides or halohydrins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/321,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
BE171148A 1975-10-01 1976-10-01 Composes et compositions a activite antiallergique et anti-anaphylactique, BE846837A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7510988A SE7510988L (sv) 1975-10-01 1975-10-01 Nya farmaceutiskt aktiva foreningar

Publications (1)

Publication Number Publication Date
BE846837A true BE846837A (fr) 1977-04-01

Family

ID=20325688

Family Applications (1)

Application Number Title Priority Date Filing Date
BE171148A BE846837A (fr) 1975-10-01 1976-10-01 Composes et compositions a activite antiallergique et anti-anaphylactique,

Country Status (19)

Country Link
JP (1) JPS5242840A (enEXAMPLES)
AT (1) AT347427B (enEXAMPLES)
AU (1) AU503212B2 (enEXAMPLES)
BE (1) BE846837A (enEXAMPLES)
CS (2) CS199644B2 (enEXAMPLES)
DD (1) DD126278A5 (enEXAMPLES)
DE (1) DE2640972A1 (enEXAMPLES)
DK (1) DK141622B (enEXAMPLES)
ES (1) ES451979A1 (enEXAMPLES)
FI (1) FI762660A7 (enEXAMPLES)
FR (1) FR2326183A1 (enEXAMPLES)
GB (1) GB1542317A (enEXAMPLES)
LU (1) LU75916A1 (enEXAMPLES)
NL (1) NL7610845A (enEXAMPLES)
NO (1) NO763345L (enEXAMPLES)
NZ (1) NZ182165A (enEXAMPLES)
SE (1) SE7510988L (enEXAMPLES)
SU (2) SU638252A3 (enEXAMPLES)
ZA (1) ZA765331B (enEXAMPLES)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3163871D1 (en) 1980-07-09 1984-07-05 Draco Ab 1-(dihydroxyphenyl)-2-amino-ethanol derivatives; preparation, compositions and intermediates
EP0103830A3 (de) * 1982-09-22 1985-07-31 Bayer Ag Wachstumsfördernde Phenylethylamin-Derivate
AU705320B2 (en) * 1995-12-28 1999-05-20 Welfide Corporation 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol or a pharmaceutically acceptable acid addition salt thereof for use in the preparation of a non-oral medicament, and for treatment of diseases and disorders
EA016485B1 (ru) 2003-06-17 2012-05-30 Арена Фармасьютикалз, Инк. Способы получения 3-бензазепинов
EP2471779A1 (en) 2006-04-03 2012-07-04 Arena Pharmaceuticals, Inc. Process for the resolution of a mixture of (R)- and (S)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
JP5404414B2 (ja) 2006-12-05 2014-01-29 アリーナ ファーマシューティカルズ, インコーポレイテッド (r)−8−クロロ−1−メチル−2,3,4,5−テトラヒドロ−1h−3−ベンゾアゼピンおよびその中間体を調製するための方法
RU2361604C1 (ru) * 2007-10-29 2009-07-20 Федеральное агентство по высокотехнологичной медицинской помощи Федеральное государственное учреждение "Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии" (ФГУ УрНИИДВиИ Росмедтехнологий) Способ лечения атопического дерматита
JP5491421B2 (ja) 2008-03-04 2014-05-14 アリーナ ファーマシューティカルズ, インコーポレイテッド 5−ht2cアゴニストである(r)−8−クロロ−1−メチル−2,3,4,5−テトラヒドロ−1h−3−ベンゾアゼピンに関連する中間体の調製のためのプロセス
EP2443080A2 (en) 2009-06-18 2012-04-25 Arena Pharmaceuticals, Inc. Process for the preparation of 5-ht2c receptor agonists
KR20130112848A (ko) 2010-06-02 2013-10-14 아레나 파마슈티칼스, 인크. 5-ht2c 수용체 아고니스트의 제조 방법
CA2808912C (en) 2010-09-01 2019-09-17 Zezhi Jesse Shao Modified-release dosage forms of 5-ht2c agonists useful for weight management
MX2013002418A (es) 2010-09-01 2013-08-01 Arena Pharm Inc Administracion de lorcaserina a individuos con daño renal.
SG10201506865WA (en) 2010-09-01 2015-10-29 Arena Pharm Inc Non-hygroscopic salts of 5-ht2c agonists
WO2012030938A1 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Salts of lorcaserin with optically active acids
AR088670A1 (es) 2012-10-09 2014-06-25 Arena Pharm Inc Metodo de control del peso

Also Published As

Publication number Publication date
AU503212B2 (en) 1979-08-30
FR2326183A1 (fr) 1977-04-29
SU638252A3 (ru) 1978-12-15
DK439776A (enEXAMPLES) 1977-04-02
DK141622B (da) 1980-05-12
ES451979A1 (es) 1978-01-01
GB1542317A (en) 1979-03-14
ATA682376A (de) 1978-05-15
SE7510988L (sv) 1977-04-02
CS199643B2 (en) 1980-07-31
AT347427B (de) 1978-12-27
FI762660A7 (enEXAMPLES) 1977-04-02
JPS5242840A (en) 1977-04-04
AU1812276A (en) 1978-04-06
ZA765331B (en) 1977-08-31
NZ182165A (en) 1978-07-10
NO763345L (enEXAMPLES) 1977-04-04
CS199644B2 (en) 1980-07-31
SU674669A3 (ru) 1979-07-15
LU75916A1 (enEXAMPLES) 1978-05-16
DE2640972A1 (de) 1977-04-14
DD126278A5 (enEXAMPLES) 1977-07-06
NL7610845A (nl) 1977-04-05

Similar Documents

Publication Publication Date Title
SE393030B (sv) Hopsettbar leksaksfigur
MC1101A1 (fr) Composition a activite retardee
EG12712A (en) Phenoxy-phenoxypropionic acid derivatives
NZ182908A (en) 2-tertiaryaminoindol-3-ylcarboxylic acid derivatives
NL7606655A (nl) Imidylbenzeendi- en -tricarbonzuurderivaten.
BE846837A (fr) Composes et compositions a activite antiallergique et anti-anaphylactique,
BE847718A (fr) Nouveaux composes a activite anti-fertilite,
GB1518449A (en) Hydroxybenzylmalonic acid derivatives
ZA774737B (en) Novel azolyl-carboxylic acid derivatives and their use as fungicides
GB1548820A (en) 9-thia11- oxo -12 - azaprotanoic acid derivatives
AU506250B2 (en) Clavulanic acid derivatives
NL7704174A (nl) Nieuwe m-fenylfenoxypropionzuurderivaten en de bereidingswijze daarvan.
GB1554299A (en) Phenylacetic acid derivatives
BE828690A (fr) Composes a activite anti-allergique
FR2293204A1 (fr) 6-methylergolines 8,8-disubstituees et composes apparentes
ZA774388B (en) Novel phenoxy-phenoxy-alkanecarboxylic acid derivatives
FR2333497A2 (fr) Composes azotes
BE843416A (fr) Nouveaux composes a activite pesticide
GB1539897A (en) Phenoxypropionic acid derivatives
IL51605A0 (en) Phenoxyphenoxy-alkanecarboxylic acid derivatives
JPS5212177A (en) Azanaphthaleneacetic acid derivatives
IE43457L (en) 1-deoxyribofuranuronic acid derivatives
JPS52111556A (en) Glycylretinic acid derivatives
BE854690A (fr) Composition antiallergique
IL49798A (en) 6-( -amino - (3,4-methylenedioxy-phenyl)-acylamido) penicilanic acid derivatives